SCHEMBL29567009

SCHEMBL29567009

Cc1cccc(C)c1-c1cc(Oc2ccc(P(C)(C)=O)cc2)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ BRD4 O60885 2/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ PIK3CB P42338 1/20 0.33
▸ MTOR P42345 1/20 0.33
▸ PIK3CG P48736 1/20 0.33
▸ HTR1A P08908 4/20 0.33
▸ HTR7 P34969 4/20 0.33
▸ EGFR P00533 2/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ SLC8A1 P32418 1/20 0.31
▸ AURKA O14965 2/20 0.31
▸ AURKB Q96GD4 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310138 1.00 TSHR (0.35) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL26810238 0.89 SMN1; SMN2 (0.38) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL29566612 0.89 TSHR (0.43) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL24310345 0.89 TSHR (0.43) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL29566748 0.88 GAA (0.40) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL24310086 0.88 GAA (0.40) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL26810218 0.88 KMT2A (0.40) TSHRSMN1; SMN2EGFRFGFR1KDR
SCHEMBL24310136 0.88 TSHR (0.33) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL29566661 0.88 TSHR (0.33) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB
SCHEMBL26857058 0.88 TSHR (0.36) TSHRSMN1; SMN2BRD4PIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback